Overview
Prophylactic Norepinephrine Infusion Combined With Colloid Coloading for Postspinal Anesthesia Hypotension
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2022-10-31
2022-10-31
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The purpose of this study is to investigate the suitable infusion dose of prophylactic norepinephrine infusion combined with 6% Hydroxyethyl starch (130/0.4) coload for post-spinal anesthesia hypotension in patients undergoing cesarean section.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
General Hospital of Ningxia Medical UniversityTreatments:
Norepinephrine
Vasoconstrictor Agents
Criteria
Criteria: Inclusion Criteria:- 18-40 years
- Primipara or multipara
- Singleton pregnancy ≥ 37 weeks
- American Society of Anesthesiologists physical status classification I to II
- Scheduled for elective cesarean section under spinal anesthesia
Exclusion Criteria:
- Body height < 150 cm
- Body weight > 100 kg or body mass index (BMI) ≥ 40 kg/m2
- Eclampsia or chronic hypertension or baseline blood pressure ≥ 160mmHg
- Hemoglobin < 7g/dl
- Coagulation or renal function disorders
- Known allergy to hydroxyethyl starch
- Fetal distress, or known fetal developmental anomaly